Brief: Mabion Q2 Net Loss At 15.4 Million Zlotys
08/10/2025 14:18
Oct 8 (Reuters) - Mabion SA MABP.WA: Q2 NET LOSS 15.4 MILLION ZLOTYS Q2 OPERATING LOSS 14.6 MILLION ZLOTYS Q2 SALES REVENUE 3.2 MILLION ZLOTYS Source text: nEMyR7wMa Further company coverage: MABP.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Partner Oddifact Says FDA Consultations Allow MabionCD20 To Be Used As First-Line Therapy For ITP
Brief: Mabion Holds Pre-IND Type B Meeting With FDA On MabionCD20 Development For ITP
Brief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Q2 Net Loss At 15 Mln Zlotys
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects